The Percutaneous Cholangiopancreatoscopy (PCPS) registry is an observational, multicentric, prospective, and retrospective registry of patients undergoing the percutaneous cholangiopancreatoscopy procedure at sites across the United States. In the retrospective component of the study, clinical and procedural data regarding patients who have undergone clinical indicated percutaneous cholangiopancreatoscopy procedure in the past will be collected from all the registry sites and stored in a secure database. The prospective component of the registry will run for three years at each site where patients undergoing the clinically indicated percutaneous cholangiopancreatoscopy procedure will be enrolled in the study, and the patients' data will be collected whenever the patients present to interventional radiology (IR) for a procedure or clinic visit.

Stanford Investigator(s):

Alexander Vezeridis, MD, PhD

Eligibility

Inclusion Criteria:

• Participant is expected to be treated for acute biliary stones, cholangiocarcinoma, intrahepatic biliary stricture, cholelithiasis, or choledocholithiasis and not surgical candidate due to comorbidities or cannot undergo/ have failed conventional endoscopic retrograde cholangiopancreatography (ERCP).
• Participant or legally authorized representative must provide written informed consent
• Participant must be ≥ 18-100 years of age.

Exclusion Criteria:

• Participant is pregnant or lactating.
• Participants is < 18 years of age.
  

Ages Eligible for Study

18 Years and older

Genders Eligible for Study

All